Healthcare provider profile · identity verified

Mitchell Ryan Davis, MD

Family Practice · ADA, OK · NPI 1346227113

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	574	66
Fluticasone Propionate	Fluticasone Propionate	439	66
Potassium Chloride	Potassium Chloride	432	52
Losartan Potassium	Losartan Potassium	426	49
Synthroid	Levothyroxine Sodium	420	49
Omeprazole	Omeprazole	383	48
Diclofenac Sodium	Diclofenac Sodium	357	65
Amlodipine Besylate	Amlodipine Besylate	316	41
Montelukast Sodium	Montelukast Sodium	302	33
Furosemide	Furosemide	268	33
Gabapentin	Gabapentin	257	33
Celecoxib	Celecoxib	242	41
Atorvastatin Calcium	Atorvastatin Calcium	231	32
Ozempic	Semaglutide	199	31
Tamsulosin Hcl	Tamsulosin Hcl	199	23
Duloxetine Hcl	Duloxetine Hcl	193	26
Pantoprazole Sodium	Pantoprazole Sodium	191	32
Lisinopril	Lisinopril	189	26
Hydrochlorothiazide	Hydrochlorothiazide	184	22
Eliquis	Apixaban	183	22
Metoprolol Succinate	Metoprolol Succinate	181	27
Spiriva Respimat	Tiotropium Bromide	156	23
Enalapril Maleate	Enalapril Maleate	147	16
Metoprolol Tartrate	Metoprolol Tartrate	134	19
Ezetimibe	Ezetimibe	126	15
Simvastatin	Simvastatin	118	15
Ibuprofen	Ibuprofen	107	12
Metformin Hcl	Metformin Hcl	107	12
Albuterol Sulfate Hfa	Albuterol Sulfate	96	35
Clopidogrel	Clopidogrel Bisulfate	94	11
Carvedilol	Carvedilol	91	11
Metformin Hcl Er	Metformin Hcl	88	11
Hydroxyzine Hcl	Hydroxyzine Hcl	85	16
Pregabalin	Pregabalin	83	suppressed
Jardiance	Empagliflozin	81	12
Famotidine	Famotidine	79	15
Meloxicam	Meloxicam	75	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	74	11
Estradiol	Estradiol	72	12
Irbesartan	Irbesartan	72	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	68	13
Allopurinol	Allopurinol	64	suppressed
Tramadol Hcl	Tramadol Hcl	62	suppressed
Atenolol	Atenolol	60	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	60	suppressed
Sertraline Hcl	Sertraline Hcl	59	suppressed
Baclofen	Baclofen	58	suppressed
Dulera	Mometasone/Formoterol	57	suppressed
Clonidine Hcl	Clonidine Hcl	56	suppressed
Lactulose	Lactulose	56	suppressed
Trazodone Hcl	Trazodone Hcl	56	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	55	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	54	12
Doxazosin Mesylate	Doxazosin Mesylate	53	suppressed
Ropinirole Hcl	Ropinirole Hcl	53	suppressed
Spironolactone	Spironolactone	53	suppressed
Methocarbamol	Methocarbamol	50	suppressed
Colestipol Hcl	Colestipol Hcl	49	suppressed
Topiramate	Topiramate	49	suppressed
Alendronate Sodium	Alendronate Sodium	45	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	44	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	42	42
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	42	suppressed
Klor-Con 10	Potassium Chloride	42	suppressed
Alogliptin	Alogliptin Benzoate	40	suppressed
Nifedipine Er	Nifedipine	40	suppressed
Acyclovir	Acyclovir	39	suppressed
Chlorthalidone	Chlorthalidone	39	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	39	suppressed
Nebivolol Hcl	Nebivolol Hcl	39	suppressed
Citalopram Hbr	Citalopram Hydrobromide	38	suppressed
Prednisone	Prednisone	38	25
Amitriptyline Hcl	Amitriptyline Hcl	36	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	36	suppressed
Buspirone Hcl	Buspirone Hcl	35	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	35	suppressed
Solifenacin Succinate	Solifenacin Succinate	34	suppressed
Bupropion Hcl Sr	Bupropion Hcl	32	suppressed
Donepezil Hcl	Donepezil Hcl	32	suppressed
Finasteride	Finasteride	31	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	31	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	30	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	29	suppressed
Fenofibric Acid	Fenofibric Acid (Choline)	27	suppressed
Naproxen	Naproxen	27	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	26	suppressed
Trueplus Pen Needle	Pen Needle, Diabetic	26	suppressed
Tresiba Flextouch U-100	Insulin Degludec	24	suppressed
Pravastatin Sodium	Pravastatin Sodium	23	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	22	suppressed
Novolog Flexpen	Insulin Aspart	22	suppressed
Ondansetron Odt	Ondansetron	22	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	22	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	21	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	20	suppressed
Doxepin Hcl	Doxepin Hcl	19	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Myrbetriq	Mirabegron	18	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	17	suppressed
Asmanex	Mometasone Furoate	16	suppressed
Cephalexin	Cephalexin	16	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	15	suppressed
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Vascepa	Icosapent Ethyl	15	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	14	suppressed
Linzess	Linaclotide	14	suppressed
Lorazepam	Lorazepam	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Digoxin	Digoxin	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Clonidine	Clonidine	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	12	suppressed
Mesalamine Er	Mesalamine	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	suppressed
Praluent Pen	Alirocumab	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	11	11
Armour Thyroid	Thyroid,pork	11	suppressed
Calcitriol	Calcitriol	11	suppressed
Carbamazepine	Carbamazepine	11	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	11	suppressed
Etodolac	Etodolac	11	suppressed
Glyburide	Glyburide	11	suppressed
Methotrexate	Methotrexate Sodium	11	suppressed
Minoxidil	Minoxidil	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Phenobarbital	Phenobarbital	11	suppressed
Potassium Citrate Er	Potassium Citrate	11	suppressed
Selenium Sulfide	Selenium Sulfide	11	suppressed
Sotalol	Sotalol Hcl	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error